Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A4513 Lestaurtinib1 CitationSummary: JAK2/FLT3/TrkA inhibitor
-
A2949 Linifanib (ABT-869)Target: VEGFR|PDGFRSummary: VEGFR/PDGFR inhibitor
-
A2977 Cabozantinib (XL184, BMS-907351)Summary: VEGFR2/Met/Ret/Kit/FLT//AXL inhibitor
-
A5467 Ponatinib (AP24534)1 CitationTarget: VEGFR|PDGFR|Bcr-Abl|FGFR|SrcSummary: pan-BCR-ABL inhibitor,multi-kinase inhibitor
-
A5793 Quizartinib (AC220)Target: FLT3Summary: FLT3 inhibitor,potent and selective
-
A2323 TCS 359Summary: Potent FLT3 inhibitor
-
B1526 Tandutinib (MLN518)Summary: FLT3 inhibitor,potent and selective
-
A3794 SB1317Summary: CDK,JAK and FLT inhibitor
-
A3818 SilvestrolSummary: Antineoplastic
-
A3847 SU5416Target: VEGFRSummary: VEGF receptor inhibitor and AHR agonist